Trials / Completed
CompletedNCT02239692
A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy
A Randomised, Assessor-blinded, Multi-centre Trial Comparing the Efficacy, Safety and Tolerability of the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 204 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This was a phase 3, randomised, assessor-blinded, multi-centre trial comparing the efficacy, safety and tolerability of a PICOPREP tailored dosing schedule to the PICOPREP day-before dosing schedule for colon cleansing in preparation for colonoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PICOPREP | Sodium Picosulfate, Magnesium Oxide and Citric Acid as PICOPREP powder for oral solution |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2014-09-15
- Last updated
- 2016-06-23
- Results posted
- 2016-06-23
Locations
3 sites across 3 countries: France, Germany, Netherlands
Source: ClinicalTrials.gov record NCT02239692. Inclusion in this directory is not an endorsement.